TONY HEIAR: Open Payments
NPI 1538316534 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 46 payments from 26 companies in 2025. Trend: 2023 $212 · 2024 $480 · 2025 $1,008
Food & beverage: $900Education: $108
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $181 |
| ABBVIE INC. | 7 | $175 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Aveo Pharmaceuticals, Inc. | 3 | $55 |
| PFIZER INC. | 3 | $54 |
| GENZYME CORPORATION | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| BeiGene USA, Inc. | 1 | $32 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Eisai Inc. | 1 | $27 |
Products named: ERLEADA, FOTIVDA, ENHERTU, IBRANCE, ELAHERE, EPKINLY, SARCLISA, KEYTRUDA.
Industry payments across IA — which companies pay providers there.
